CILOXAN Drug Patent Profile
✉ Email this page to a colleague
When do Ciloxan patents expire, and what generic alternatives are available?
Ciloxan is a drug marketed by Sandoz and is included in two NDAs.
The generic ingredient in CILOXAN is ciprofloxacin hydrochloride. There are thirty-four drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the ciprofloxacin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ciloxan
A generic version of CILOXAN was approved as ciprofloxacin hydrochloride by RUBICON on June 9th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CILOXAN?
- What are the global sales for CILOXAN?
- What is Average Wholesale Price for CILOXAN?
Summary for CILOXAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 92 |
Clinical Trials: | 6 |
Patent Applications: | 3,275 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CILOXAN |
Drug Sales Revenues: | Drug sales revenues for CILOXAN |
What excipients (inactive ingredients) are in CILOXAN? | CILOXAN excipients list |
DailyMed Link: | CILOXAN at DailyMed |
![CILOXAN drug patent expirations Drug patent expirations by year for CILOXAN](/p/graph/s/t/CILOXAN-patent-expirations.png)
![Drug Prices for CILOXAN](/p/graph/drug-price/CILOXAN.png)
![Drug Sales Revenue Trends for CILOXAN](/p/graph/drug-sales-revenues/CILOXAN.png)
Recent Clinical Trials for CILOXAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Santen Pharmaceutical Co., Ltd. | Phase 1/Phase 2 |
National University of Malaysia | Phase 1/Phase 2 |
CR-CSSS Champlain-Charles-Le Moyne | Phase 3 |
Pharmacology for CILOXAN
Drug Class | Quinolone Antimicrobial Fluoroquinolone Antibacterial |
Mechanism of Action | Cytochrome P450 1A2 Inhibitors |
US Patents and Regulatory Information for CILOXAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | CILOXAN | ciprofloxacin hydrochloride | OINTMENT;OPHTHALMIC | 020369-001 | Mar 30, 1998 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sandoz | CILOXAN | ciprofloxacin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019992-001 | Dec 31, 1990 | AT | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CILOXAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sandoz | CILOXAN | ciprofloxacin hydrochloride | OINTMENT;OPHTHALMIC | 020369-001 | Mar 30, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Sandoz | CILOXAN | ciprofloxacin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019992-001 | Dec 31, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CILOXAN
See the table below for patents covering CILOXAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Ireland | 53709 | 1-CYCLOPROPYL-6-FLUORO-1, 4-DIHYDRO-4-OXO-7-PIPERAZINO-QUINOLINE-3-CARBOXYLIC ACIDS, A PROCESS FOR THEIR PREPARATION AND ANTI-BACTERIAL AGENTS CONTAINING THESE COMPOUNDS | ⤷ Sign Up |
Japan | S5777683 | 7-AMINO-1-CYCLOPROPYL-4-OXO-1,4-DIHYDRO- NAPHTHYRIDINE-3-CARBOXYLIC ACIDS OR SALTS THEREOF, MANUFACTURE AND ANTIBACTERIAL THEREOF AS ACTIVE INGREDIENT | ⤷ Sign Up |
Japan | S6322075 | 1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7- PIPERAZINOQUINOLINE-3-CARBOXYLIC ACIDS | ⤷ Sign Up |
European Patent Office | 0049355 | 7-AMINO-1-CYCLOPROPYL-4-OXO-1,4-DIHYDRO-NAPHTHYRIDINE-3-CARBOXYLIC ACIDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ⤷ Sign Up |
Japan | S6322076 | QUINOLINE DERIVATIVE | ⤷ Sign Up |
Germany | 3273892 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for CILOXAN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1429780 | SPC/GB12/058 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003 |
1429780 | 122012000070 | Germany | ⤷ Sign Up | PRODUCT NAME: KOMBINATION AUS CIPROFLOXACIN UND DEXAMETHASON, INSBESONDERE CIPROFLOXACINHYDROCHLORID UND DEXAMETHASON; NAT. REGISTRATION NO/DATE: 85150.00. 00 20120830; FIRST REGISTRATION: DAENEMARK 48976 20120808 |
1429780 | 13C0012 | France | ⤷ Sign Up | PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808 |
1429780 | 132013902137451 | Italy | ⤷ Sign Up | PRODUCT NAME: CIPROFLOXACINA E DESAMETASONE(CILODEX); AUTHORISATION NUMBER(S) AND DATE(S): 48976, 20120810;041182015/M, 20121106 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |